XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenues - Revenues Disaggregated by Concentration Risks (Details) - Customer Concentration Risk
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Dec. 31, 2021
Affiliates of McKesson Corporation | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 18.00% 15.00% 18.00% 15.00%  
Affiliates of McKesson Corporation | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     23.00%   10.00%
Affiliates of CVS Health Corporation | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 19.00% 16.00% 17.00% 15.00%  
Affiliates of CVS Health Corporation | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     15.00%   9.00%
Affiliates of AmerisourceBergen Corporation | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 18.00% 16.00% 16.00% 14.00%  
Affiliates of AmerisourceBergen Corporation | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     20.00%   11.00%
Ipsen Pharma SAS | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 8.00% 12.00% 11.00% 17.00%  
Ipsen Pharma SAS | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     21.00%   50.00%
Accredo Health, Incorporated | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 11.00% 9.00% 10.00% 8.00%